This kit is specifically designed for in vitro quantitative screening of the concentration of Creatine kinase-MB (CK-MB) protein in human serum, plasma, and whole blood samples. Automated and objective results in 15 minutes by immunofluorescent assay.
– Helps to evaluate and examine the diagnosis, prognosis,
and evaluation of heart damage
– Easy-to-understand interpretation by printer
– Can reconnect to the old results by ID Chip
– Easy-operable interface
– Maximized accuracy and sensitivity
– Minimum time interval to maximum accuracy
– ID Chip
– Test Cassette
– Sample Diluent
– Pipette
– User Manual
Intended use | Detection of SARS-CoV-2 antigen |
---|---|
Storage | 2-30℃ / 35.6-86℉ |
Specimen type | Nasal swab |
Time to result | 15-30 minutes |
Shelf life | 24 months |
Sensitivity | 93.1% |
Specificity | 100.0% |
.embed-container { position: relative; padding-bottom: 56.25%; height: 0; overflow: hidden; max-width: 100%; } .embed-container iframe, .embed-container object, .embed-container embed { position: absolute; top: 0; left: 0; width: 100%; height: 100%; }
Ref. No. |
Target |
Specimen |
Kit Size |
Certification |
---|---|---|---|---|
VMPO18 |
CK-MB Protein |
S/P/WB |
25 T |
S:Serum, P:Plasma, WB:Whole Blood